Home
>
National Drug Code (NDC)
>
ZANAFLEX
ZANAFLEX - 16590-871-30 - (TIZANIDINE HYDROCHLORIDE)
Drug Information of ZANAFLEX
| Product NDC: | 16590-871 |
| Proprietary Name: | ZANAFLEX |
| Non Proprietary Name: | TIZANIDINE HYDROCHLORIDE |
| Active Ingredient(s): | 4 mg/1 & nbsp; TIZANIDINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZANAFLEX
| Product NDC: | 16590-871 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021447 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020829 |
Package Information of ZANAFLEX
| Package NDC: | 16590-871-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (16590-871-30) |
NDC Information of ZANAFLEX
| NDC Code | 16590-871-30 |
| Proprietary Name | ZANAFLEX |
| Package Description | 30 CAPSULE in 1 BOTTLE (16590-871-30) |
| Product NDC | 16590-871 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TIZANIDINE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20020829 |
| Marketing Category Name | NDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
